TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
PRLD

Prelude Therapeutics Inc

Healthcare · Biotechnology

3.70$ -3.2% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement PRLD
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – +73.4%
– +156.4% +41.9% +313.8% +35.6% -61.6% +51.6% -3.4%
– – – – – – – +49.0%
– +92.4% +98.4% +80.1% +7.0% +11.3% +14.1% -20.1%
– +62.7% +176.4% +154.6% +13.7% -5.8% -0.6% -22.0%
– +87.7% +109.1% +93.5% +8.6% +7.1% +10.9% -21.6%
– – – – – – – –
– – – – -35.1% – – –
– – – – – – – –
– -28.8% +59.8% -372.6% – – – –
– – – – – – – –
– – – – – – – –

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?